" class="no-js "lang="en-US"> Philip Adamson - Medtech Alert
Friday, June 20, 2025
Philip Adamson

Philip Adamson

About Philip Adamson

Experienced Divisional Vice President and Chief Medical Officer for the Heart Failure Division of Abbott.
Demonstrated history of working in Clinical trial design and execution. Also accomplished in US and international regulatory relationships, as well as reimbursement (US Medicare and Medicaid, NICE, EU).
Experienced in hospital & health care industry with skills medical devices., Cardiology and Leadership. Strong healthcare services professional with a Doctor of Medicine – MD and a Master of Science focused in Cardiovascular Physiology from University of Oklahoma Health Sciences Center.

Related Story

Abbott's CardioMEMS™ HF System Receives FDA Approval to Support Patients Battling Earlier-stage Heart Failure

February 22 2022

Abbott today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded […]

Abbott New Trial Seeks Better Treatment for AFib and Heart Failure

May 10 2021

Abbott (NYSE: ABT) today announced a new trial focused on improving the treatment for people simultaneously […]